LXRX - Lexicon Pharmaceuticals Inc Profit before interest, taxes and amortization
The launch of treatments for diabetes and heart failure is creating growth momentum reflected in the operating financial results on the GURU.Markets chart, where 0.00 captures the current indicator value. Lexicon Pharmaceuticals (LXRX) revenues are based on the commercialization of innovative drugs and partnerships. Management must now overcome insurance coverage challenges to achieve full business profitability.
Summary analytical data breakdowns for Lexicon Pharmaceuticals, Inc. (LXRX)
- current quotes and average value forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Debt to Equity Lexicon Pharmaceuticals|LXRX - Long-Term Debt to Equity|Current Liabilities to Capital Lexicon Pharmaceuticals Inc|LXRX - Company Debts|Debt to Book Capitalization Ratio Lexicon Pharmaceuticals|LXRX - Company Long-Term Debts|Short-Term Debt Volume Lexicon Pharmaceuticals|Interim Coverage Ratio lexpharma.com
- financial results and valuation multiples details:
LXRX - Company Net Income|Future Profit Lexicon Pharmaceuticals|LXRX - Price to Earnings Ratio|Future Price to Earnings lexpharma.com|LXRX - PEG Multiple|Company Value to EBITDA Lexicon Pharmaceuticals|LXRX - Operating profit before deduction of amortization|Earnings per share for the last 12 months Lexicon Pharmaceuticals|LXRX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months lexpharma.com|LXRX - Earnings growth in current year|Expected earnings per share growth for next year Lexicon Pharmaceuticals
Analysis of all company metrics:Lexicon Corp (LXRX)
Lexicon Pharmaceuticals (LXRX) specializes in scaling patents through outsourced production, which minimizes capital expenditures and increases operating margins. By analyzing EBITDA, an investor can identify the net cash flow from core operations, allowing for an assessment of the business's ability to generate liquidity regardless of debt load and depreciation, thereby minimizing the risks of frozen capital.
Who Lexicon Pharmaceuticals competes with
ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Corp) - Operating profit EBITDA|Operating profit EBITDA MoonLake Corp|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (newamsterdampharma.com)|Profit before payment of interest, taxes and amortization Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Profit before interest, taxes and amortization|ETNB - Profit before payment of interest, taxes and amortization|AGIO: Profit before payment of interest, taxes and amortization|GPCR: Operating profit EBITDA|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute|MBX Biosciences, Inc. (MBX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Altimmune Corp (ALT)|Operating profit before deduction of amortization Aardvark Pharma AARD|Profit before payment of interest, taxes and amortization Sagimet Biosciences SGMT|bioagelabs.com - Profit before payment of interest, taxes and amortization|Biomea Fusion - Operating profit EBITDA|Profit before interest, taxes and amortization Quince Therapeutics|GUTS (Fractyl) - Operating profit before deduction of amortization|Operating profit before amortization VTVT|ATPC (Agape ATP Corp) - Operating profit EBITDA|Pluri Inc (PLUR) - Operating income before deduction of amortization|Operating profit EBITDA SYBX|Operating profit before deduction of amortization Lipocine Inc LPCN|Profit before payment of interest, taxes and amortization Matinas BioPharma Holdings MTNB|sprucebiosciences.com (SPRB) - Profit before interest, taxes and amortization|GLTO - Profit before payment of interest, taxes and amortization|CTCX (carmellrx.com) - Operating profit before amortization|LUMO (Lumos Pharma) - Operating profit before deduction of amortization|Organovo Holdings - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Radius Health
